HQ SPCLT PHARMA RX
FDA Approved Drugs

HQ SPCLT PHARMA RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 33
  • Latest Approval Date Nov 18, 2025
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
37
View
Discontinued
4
View
RX
33
View
Company Overview

Company

HQ SPCLT PHARMA RX

Country

U.S.A

Website

Email

Social Profiles

Company Snapshot

HQ SPCLT PHARMA RX

U.S.A

View on Map
FDA Approved Drug Records ( 33 records )
2025
18 Nov
RX Application: 210906

Drug Name

CALCIUM GLUCONATE

Product Number

4

Dosage Form

-

Strength

10GM/100ML (100MG/ML)

Approval Date

2025-11-18

210906 / 4

Active Ingredient

CALCIUM GLUCONATE

Application Number

210906

Product Number

4

Dosage Form

-

Strength

10GM/100ML (100MG/ML)

Approval Date

2025-11-18

Regulatory Status

RX

2018
29 Oct
RX Application: 210906

Drug Name

CALCIUM GLUCONATE IN SODIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

1GM/50ML (20MG/ML)

Approval Date

2018-10-29

210906 / 1

Active Ingredient

CALCIUM GLUCONATE

Application Number

210906

Product Number

1

Dosage Form

-

Strength

1GM/50ML (20MG/ML)

Approval Date

2018-10-29

Regulatory Status

RX

2018
29 Oct
RX Application: 210906

Drug Name

CALCIUM GLUCONATE IN SODIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

2GM/100ML (20MG/ML)

Approval Date

2018-10-29

210906 / 2

Active Ingredient

CALCIUM GLUCONATE

Application Number

210906

Product Number

2

Dosage Form

-

Strength

2GM/100ML (20MG/ML)

Approval Date

2018-10-29

Regulatory Status

RX

2021
04 Jun
RX Application: 210906

Drug Name

CALCIUM GLUCONATE IN SODIUM CHLORIDE

Product Number

3

Dosage Form

-

Strength

1GM/100ML (10MG/ML)

Approval Date

2021-06-04

210906 / 3

Active Ingredient

CALCIUM GLUCONATE

Application Number

210906

Product Number

3

Dosage Form

-

Strength

1GM/100ML (10MG/ML)

Approval Date

2021-06-04

Regulatory Status

RX

2023
08 May
RX Application: 211413

Drug Name

CEFAZOLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2023-05-08

211413 / 1

Active Ingredient

CEFAZOLIN SODIUM

Application Number

211413

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2023-05-08

Regulatory Status

RX

2024
08 Mar
RX Application: 211413

Drug Name

CEFAZOLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 3GM BASE/VIAL

Approval Date

2024-03-08

211413 / 2

Active Ingredient

CEFAZOLIN SODIUM

Application Number

211413

Product Number

2

Dosage Form

-

Strength

EQ 3GM BASE/VIAL

Approval Date

2024-03-08

Regulatory Status

RX

1982
01 Jan
RX Application: 18057

Drug Name

CISPLATIN

Product Number

2

Dosage Form

-

Strength

50MG/VIAL

Approval Date

1982-01-01

18057 / 2

Active Ingredient

CISPLATIN

Application Number

18057

Product Number

2

Dosage Form

-

Strength

50MG/VIAL

Approval Date

1982-01-01

Regulatory Status

RX

1988
08 Nov
RX Application: 18057

Drug Name

CISPLATIN

Product Number

4

Dosage Form

-

Strength

1MG/ML

Approval Date

1988-11-08

18057 / 4

Active Ingredient

CISPLATIN

Application Number

18057

Product Number

4

Dosage Form

-

Strength

1MG/ML

Approval Date

1988-11-08

Regulatory Status

RX

2015
21 Oct
RX Application: 206628

Drug Name

DEXMEDETOMIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML)

Approval Date

2015-10-21

206628 / 1

Active Ingredient

DEXMEDETOMIDINE HYDROCHLORIDE

Application Number

206628

Product Number

1

Dosage Form

-

Strength

EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML)

Approval Date

2015-10-21

Regulatory Status

RX

2015
21 Oct
RX Application: 206628

Drug Name

DEXMEDETOMIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE/10ML (EQ 100MCG BASE/ML)

Approval Date

2015-10-21

206628 / 2

Active Ingredient

DEXMEDETOMIDINE HYDROCHLORIDE

Application Number

206628

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE/10ML (EQ 100MCG BASE/ML)

Approval Date

2015-10-21

Regulatory Status

RX

2018
22 Jun
RX Application: 206628

Drug Name

DEXMEDETOMIDINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

Approval Date

2018-06-22

206628 / 3

Active Ingredient

DEXMEDETOMIDINE HYDROCHLORIDE

Application Number

206628

Product Number

3

Dosage Form

-

Strength

EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

Approval Date

2018-06-22

Regulatory Status

RX

2018
22 Jun
RX Application: 206628

Drug Name

DEXMEDETOMIDINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

Approval Date

2018-06-22

206628 / 4

Active Ingredient

DEXMEDETOMIDINE HYDROCHLORIDE

Application Number

206628

Product Number

4

Dosage Form

-

Strength

EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

Approval Date

2018-06-22

Regulatory Status

RX

2025
21 Feb
RX Application: 218038

Drug Name

DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG/100ML (1MG/ML)

Approval Date

2025-02-21

218038 / 1

Active Ingredient

DILTIAZEM HYDROCHLORIDE

Application Number

218038

Product Number

1

Dosage Form

-

Strength

100MG/100ML (1MG/ML)

Approval Date

2025-02-21

Regulatory Status

RX

2025
21 Feb
RX Application: 218038

Drug Name

DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

250MG/250ML (1MG/ML)

Approval Date

2025-02-21

218038 / 2

Active Ingredient

DILTIAZEM HYDROCHLORIDE

Application Number

218038

Product Number

2

Dosage Form

-

Strength

250MG/250ML (1MG/ML)

Approval Date

2025-02-21

Regulatory Status

RX

2022
02 Dec
RX Application: 214172

Drug Name

ESMOLOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

1GM/100ML

Approval Date

2022-12-02

214172 / 1

Active Ingredient

ESMOLOL HYDROCHLORIDE

Application Number

214172

Product Number

1

Dosage Form

-

Strength

1GM/100ML

Approval Date

2022-12-02

Regulatory Status

RX

2022
02 Dec
RX Application: 214172

Drug Name

ESMOLOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

2GM/100ML

Approval Date

2022-12-02

214172 / 2

Active Ingredient

ESMOLOL HYDROCHLORIDE

Application Number

214172

Product Number

2

Dosage Form

-

Strength

2GM/100ML

Approval Date

2022-12-02

Regulatory Status

RX

2016
07 Apr
RX Application: 205703

Drug Name

ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER

Product Number

2

Dosage Form

-

Strength

2GM/100ML (20MG/ML)

Approval Date

2016-04-07

205703 / 2

Active Ingredient

ESMOLOL HYDROCHLORIDE

Application Number

205703

Product Number

2

Dosage Form

-

Strength

2GM/100ML (20MG/ML)

Approval Date

2016-04-07

Regulatory Status

RX

2016
07 Apr
RX Application: 205703

Drug Name

ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Product Number

1

Dosage Form

-

Strength

2.5GM/250ML (10MG/ML)

Approval Date

2016-04-07

205703 / 1

Active Ingredient

ESMOLOL HYDROCHLORIDE

Application Number

205703

Product Number

1

Dosage Form

-

Strength

2.5GM/250ML (10MG/ML)

Approval Date

2016-04-07

Regulatory Status

RX

2019
12 Dec
RX Application: 207594

Drug Name

IMIPENEM AND CILASTATIN

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL;500MG/VIAL

Approval Date

2019-12-12

207594 / 1

Active Ingredient

CILASTATIN SODIUM; IMIPENEM

Application Number

207594

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL;500MG/VIAL

Approval Date

2019-12-12

Regulatory Status

RX

2011
09 Nov
RX Application: 202543

Drug Name

LEVETIRACETAM IN SODIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG/100ML (5MG/ML)

Approval Date

2011-11-09

202543 / 1

Active Ingredient

LEVETIRACETAM

Application Number

202543

Product Number

1

Dosage Form

-

Strength

500MG/100ML (5MG/ML)

Approval Date

2011-11-09

Regulatory Status

RX

2011
09 Nov
RX Application: 202543

Drug Name

LEVETIRACETAM IN SODIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

1GM/100ML (10MG/ML)

Approval Date

2011-11-09

202543 / 2

Active Ingredient

LEVETIRACETAM

Application Number

202543

Product Number

2

Dosage Form

-

Strength

1GM/100ML (10MG/ML)

Approval Date

2011-11-09

Regulatory Status

RX

2011
09 Nov
RX Application: 202543

Drug Name

LEVETIRACETAM IN SODIUM CHLORIDE

Product Number

3

Dosage Form

-

Strength

1.5GM/100ML (15MG/ML)

Approval Date

2011-11-09

202543 / 3

Active Ingredient

LEVETIRACETAM

Application Number

202543

Product Number

3

Dosage Form

-

Strength

1.5GM/100ML (15MG/ML)

Approval Date

2011-11-09

Regulatory Status

RX

2017
07 Jul
RX Application: 207001

Drug Name

LINEZOLID

Product Number

1

Dosage Form

-

Strength

200MG/100ML (2MG/ML)

Approval Date

2017-07-07

207001 / 1

Active Ingredient

LINEZOLID

Application Number

207001

Product Number

1

Dosage Form

-

Strength

200MG/100ML (2MG/ML)

Approval Date

2017-07-07

Regulatory Status

RX

2017
07 Jul
RX Application: 207001

Drug Name

LINEZOLID

Product Number

2

Dosage Form

-

Strength

600MG/300ML (2MG/ML)

Approval Date

2017-07-07

207001 / 2

Active Ingredient

LINEZOLID

Application Number

207001

Product Number

2

Dosage Form

-

Strength

600MG/300ML (2MG/ML)

Approval Date

2017-07-07

Regulatory Status

RX

2016
02 Mar
RX Application: 207349

Drug Name

MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Product Number

1

Dosage Form

-

Strength

1GM/100ML

Approval Date

2016-03-02

207349 / 1

Active Ingredient

MAGNESIUM SULFATE

Application Number

207349

Product Number

1

Dosage Form

-

Strength

1GM/100ML

Approval Date

2016-03-02

Regulatory Status

RX

2017
06 Dec
RX Application: 207350

Drug Name

MAGNESIUM SULFATE IN PLASTIC CONTAINER

Product Number

1

Dosage Form

-

Strength

2GM/50ML (40MG/ML)

Approval Date

2017-12-06

207350 / 1

Active Ingredient

MAGNESIUM SULFATE

Application Number

207350

Product Number

1

Dosage Form

-

Strength

2GM/50ML (40MG/ML)

Approval Date

2017-12-06

Regulatory Status

RX

2017
06 Dec
RX Application: 207350

Drug Name

MAGNESIUM SULFATE IN PLASTIC CONTAINER

Product Number

2

Dosage Form

-

Strength

4GM/100ML (40MG/ML)

Approval Date

2017-12-06

207350 / 2

Active Ingredient

MAGNESIUM SULFATE

Application Number

207350

Product Number

2

Dosage Form

-

Strength

4GM/100ML (40MG/ML)

Approval Date

2017-12-06

Regulatory Status

RX

2017
06 Dec
RX Application: 207350

Drug Name

MAGNESIUM SULFATE IN PLASTIC CONTAINER

Product Number

3

Dosage Form

-

Strength

4GM/50ML (80MG/ML)

Approval Date

2017-12-06

207350 / 3

Active Ingredient

MAGNESIUM SULFATE

Application Number

207350

Product Number

3

Dosage Form

-

Strength

4GM/50ML (80MG/ML)

Approval Date

2017-12-06

Regulatory Status

RX

2017
06 Dec
RX Application: 207350

Drug Name

MAGNESIUM SULFATE IN PLASTIC CONTAINER

Product Number

4

Dosage Form

-

Strength

20GM/500ML (40MG/ML)

Approval Date

2017-12-06

207350 / 4

Active Ingredient

MAGNESIUM SULFATE

Application Number

207350

Product Number

4

Dosage Form

-

Strength

20GM/500ML (40MG/ML)

Approval Date

2017-12-06

Regulatory Status

RX

2017
06 Dec
RX Application: 207350

Drug Name

MAGNESIUM SULFATE IN PLASTIC CONTAINER

Product Number

5

Dosage Form

-

Strength

40GM/1000ML (40MG/ML)

Approval Date

2017-12-06

207350 / 5

Active Ingredient

MAGNESIUM SULFATE

Application Number

207350

Product Number

5

Dosage Form

-

Strength

40GM/1000ML (40MG/ML)

Approval Date

2017-12-06

Regulatory Status

RX

2019
16 Aug
RX Application: 210773

Drug Name

MEROPENEM

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2019-08-16

210773 / 1

Active Ingredient

MEROPENEM

Application Number

210773

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2019-08-16

Regulatory Status

RX

2019
16 Aug
RX Application: 210773

Drug Name

MEROPENEM

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2019-08-16

210773 / 2

Active Ingredient

MEROPENEM

Application Number

210773

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2019-08-16

Regulatory Status

RX

2023
26 Jul
RX Application: 215212

Drug Name

MEROPENEM

Product Number

1

Dosage Form

-

Strength

2GM/VIAL

Approval Date

2023-07-26

215212 / 1

Active Ingredient

MEROPENEM

Application Number

215212

Product Number

1

Dosage Form

-

Strength

2GM/VIAL

Approval Date

2023-07-26

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    37 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
33 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CALCIUM GLUCONATE

Application Number

210906

Product Number

4

Active Ingredient

CALCIUM GLUCONATE

Dosage Form

-

Strength

10GM/100ML (100MG/ML)

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit